We are live on
!
Find out more
GCM
Ghisallo Capital Management Portfolio holdings
AUM
$5.1B
1-Year Est. Return
39.13%
This Fund
S&P 500
This Quarter
Est. Return
+15.09%
1 Year Est. Return
+39.13%
3 Year Est. Return
+121.55%
5 Year Est. Return
+121.89%
10 Year Est. Return
–
AUM
$5.1B
AUM Growth
+$1.47B
(+40%)
Cap. Flow
+$410M
Cap. Flow
% of AUM
8.05%
Top 10 Holdings %
Top 10 Hldgs %
42.59%
Holding
458
New
148
Increased
12
Reduced
51
Closed
123
Avg Time Held
1.3
quarters
Top 10 Avg Time Held
0.3
quarters
Top 20 Avg Time Held
0.5
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$965M |
| 2 |
Digital Realty Trust
DLR
|
+$229M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$144M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$143M |
| 5 |
Super Micro Computer
SMCI
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$102M |
| 2 |
NVIDIA
NVDA
|
+$95.9M |
| 3 |
Microsoft
MSFT
|
+$92.5M |
| 4 |
GlobalFoundries
GFS
|
+$80.1M |
| 5 |
Medline Inc
MDLN
|
+$62.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 29.61% |
| 2 | Miscellaneous | 19.42% |
| 3 | Communication Services | 10.49% |
| 4 | Technology | 8.11% |
| 5 | Healthcare | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
251
Bluerock Acquisition Corp Unit
BLRKU
| $1.03M | 0.02% |
100,000
| – | – |
2025 Q4
2 quarters
|
|
252
Candel Therapeutics
CADL
$709M
| $1.03M | 0.02% |
100,000
-100,000
| -50% | -$755K |
2026 Q1
1 quarter
|
|
253
ProCap Acquisition Corp
PCAP
$331M
| $1.03M | 0.02% |
100,000
| – | – |
2025 Q3
3 quarters
|
|
254
Suja Life Inc
SUJA
$273M
| $1.02M | 0.02% |
+100,000
| New | +$1.34M |
2026 Q2
0 quarters
|
|
255
M3-Brigade Acquisition VI Corp
MBVI
$442M
| $1.01M | 0.02% |
100,000
| – | – |
2025 Q4
2 quarters
|
|
256
Blue Water Acquisition Corp IV Units
BWIV.U
| $1M | 0.02% |
100,000
| – | – |
2026 Q1
1 quarter
|
|
257
Disciplined Growth Acquisition Corp Units
DGAC.U
| $1M | 0.02% |
+100,000
| New | +$1M |
2026 Q2
0 quarters
|
|
258
ITHAX Acquisition Corp III
ITHA
$309M
| $998K | 0.02% |
100,000
| – | – |
2026 Q1
1 quarter
|
|
259
XFLH Capital Corp
XFLH
$140M
| $997K | 0.02% |
+100,000
| New | +$994K |
2026 Q2
0 quarters
|
|
260
Art Technology Acquisition Corp
ARTC
| $994K | 0.02% |
100,000
| – | – |
2026 Q1
1 quarter
|
|
261
M Evo Global Acquisition Corp II
MEVO
| $992K | 0.02% |
100,000
| – | – |
2026 Q1
1 quarter
|
|
262
Paloma Acquisition Corp I
PALO
| $990K | 0.02% |
+100,000
| New | +$989K |
2026 Q2
0 quarters
|
|
263
Jefferson Capital
JCAP
$1.18B
| $974K | 0.02% |
50,000
| – | – |
2025 Q2
4 quarters
|
|
264
Smithfield Foods
SFD
$7.17B
| $970K | 0.02% |
40,000
-35,000
| -47% | -$935K |
2025 Q1
5 quarters
|
|
265
McGraw Hill
MH
$2.57B
| $947K | 0.02% |
100,000
-150,000
| -60% | -$1.81M |
2025 Q3
3 quarters
|
|
266
Inventiva
IVA
$678M
| $945K | 0.02% |
+250,000
| New | +$1.2M |
2026 Q2
0 quarters
|
|
267
NIQ Global Intelligence PLC
NIQ
$5.4B
| $935K | 0.02% |
100,000
-150,000
| -60% | -$1.45M |
2025 Q3
3 quarters
|
|
268
Trevi Therapeutics
TRVI
$1.75B
| $933K | 0.02% |
+50,000
| New | +$727K |
2026 Q2
0 quarters
|
|
269
Lumexa Imaging Holdings
LMRI
$1.02B
| $846K | 0.02% |
75,000
| – | – |
2025 Q4
2 quarters
|
|
270
Netskope Inc
NTSK
$8.64B
| $821K | 0.02% |
75,000
-25,000
| -25% | -$255K |
2025 Q3
3 quarters
|
|
271
Aktis Oncology
AKTS
$926M
| $806K | 0.02% |
25,000
| – | – |
2026 Q1
1 quarter
|
|
272
Rare Earths Americas Inc
REA
$167M
| $764K | 0.02% |
+50,000
| New | +$986K |
2026 Q2
0 quarters
|
|
273
Celldex Therapeutics
CLDX
$2.22B
| $744K | 0.01% |
+20,000
| New | +$646K |
2026 Q2
0 quarters
|
|
274
MapLight Therapeutics
MPLT
$438M
| $717K | 0.01% |
20,000
| – | – |
2025 Q4
2 quarters
|
|
275
Senseonics Holdings Inc
SENS
$472M
| $710K | 0.01% |
+125,000
| New | +$801K |
2026 Q2
0 quarters
|
|
Similar funds
KACA
MRCP
CFO
YCM
BPCE
GIBU
ACM
BMO
Ghisallo Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Ghisallo Capital Management held 458 positions worth $5.1B, up 40% from $3.63B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Ghisallo Capital Management deployed $410M of net new capital in Q2 2026, opening 148 new positions and adding to 12 existing holdings. Its largest new stake was SpaceX: 5,678,145 shares worth $970M.
By sector, the portfolio is most concentrated in Industrials at 30% of assets, up from 17% a quarter earlier, followed by Miscellaneous and Communication Services.
On the sell side, the largest reduction was Medline Inc, an estimated $62.3M trimmed.
- Ghisallo Capital Management's largest Q2 2026 buy was SpaceX: 5,678,145 shares worth $970M.
- Ghisallo Capital Management added most to Diamondback Energy in Q2 2026, an estimated $29.1M increase.
- Ghisallo Capital Management's biggest Q2 2026 reduction was Medline Inc, cutting an estimated $62.3M.
- Ghisallo Capital Management fully exited Tesla in Q2 2026, selling an estimated $102M.
- Ghisallo Capital Management's ten largest holdings make up 43% of its $5.1B portfolio in Q2 2026.
- Ghisallo Capital Management opened 148 new positions and closed 123 in Q2 2026.
- Ghisallo Capital Management's portfolio value rose 40% quarter-over-quarter to $5.1B.
Based on Ghisallo Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.